Image Source - unsplash
Tonix Pharmaceuticals Stock Forecast 2023 to 2030
Image Source - unsplash
Tonix Pharmaceutical Holding Corporation is a popular clinical-stage biopharmaceutical firm.
Image Source - unsplash
The company focuses on making discoveries, developing/ acquiring small molecule licensing...
Image Source - unsplash
Helping to treat and prevent human diseases, and even lowering their suffering.
Image Source - unsplash
Tonix Pharmaceutical’s portfolio comprises central nervous system immunology and other infectious disease product candidates.
Image Source - unsplash
The immunology Tonix Pharmaceutical portfolio comprises biology for addressing autoimmune disease and organ transplant rejection.
Image Source - unsplash
The central nervous system of Tonix Pharmaceutical’s portfolio comprises biologics
Image Source - unsplash
Learn more